Skip to main content
. 2020 Jul 26;12:1758835920943065. doi: 10.1177/1758835920943065

Figure 1.

Figure 1.

TTD ⩾10% in global HRQoL in patients treated with RIB versus PBO.

CI, confidence interval; ET, endocrine therapy; HR, hazard ratio; HRQoL, health-related quality of life; mo, months; PBO, placebo; RIB, ribociclib; TTD, time to deterioration.